Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Anorexigens - Anorectic agents - Appetite suppressants

4

XII.b Valvular heart disease and/or dysfunction

3
Last update : 26/01/2013
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Aminorex
5
Cannabinoids - Cannabinoid receptor agonists (synthetic) (K2, Spice)
5
Dexfenfluramine
3
Dinitrophenol (2, 4-dinitrophenol or DNP)
3
Fenfluramine
3
Levamisole
4
Mazindol
1
Phentermine
3
Thyroid hormones (exogenous)
1

Publications

Benfluorex and unexplained valvular heart disease: a case-control study.
PloS one 2010 Apr 12;5;e10128 2010 Apr 12
The longitudinal effects of fenfluramine-phentermine use.
Angiology 2007;58;353-9 2007
Quantitative analysis of human heart valves: does anorexigen exposure produce a distinctive morphological lesion?
Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology 2002;11;251-62 2002
Histologic changes in three explanted native cardiac valves following use of fenfluramines.
Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology 1999;8;245-53 1999
A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation.
The New England journal of medicine 1998 Sep 10;339;719-24 1998 Sep 10
Appetite suppressants and valvular heart disease.
The New England journal of medicine 1998 Sep 10;339;765-6 1998 Sep 10
The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs.
The New England journal of medicine 1998 Sep 10;339;713-8 1998 Sep 10
Risk for valvular heart disease among users of fenfluramine and dexfenfluramine who underwent echocardiography before use of medication.
Annals of internal medicine 1998 Dec 01;129;870-4 1998 Dec 01
[Development of pulmonary hypertension and multi-valvular damage caused by appetite depressants].
Harefuah 1998 Dec 01;135;489-92, 568 1998 Dec 01

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies